Back
Perspective Therapeutics Stock Predictions
Sponsored
CATX
Sponsored
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
31
CATX
Perspective Therapeutics
Last Price:
13.55
Seasonality Move:
-10.19%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.Perspective Therapeutics Stock Forecast
- Over the next 52 weeks, Perspective Therapeutics has on average historically risen by 28.3% based on the past 20 years of stock performance.
- Perspective Therapeutics has risen higher in 6 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
-
Is Perspective Therapeutics Stock Undervalued?
The current Perspective Therapeutics [CATX] share price is $13.35. The Score for CATX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal. - CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Perspective Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Perspective Therapeutics has on average historically risen by 28.3% based on the past 20 years of stock performance.
Perspective Therapeutics Stock Rating
Sell
31
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics overpriced?
- Perspective Therapeutics has risen higher in 6 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
Perspective Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com
52-Week Data
52-Week High:
19.05
52-Week Low:
2.20
Prediction Charts
Market Cap:
900.16M
Price in USD:
13.35
Volume:
664.73K
Beta:
1.34
Technical Analysis
SMA50:
13.70
SMA100:
13.76
SMA200:
11.22
52-Wk Change:
317.32%
Stock Predictions
-
Is Perspective Therapeutics stock public?
Yes, Perspective Therapeutics is a publicly traded company. -
What is the Perspective Therapeutics stock quote today?
The Perspective Therapeutics stock price is 13.35 USD today. -
How to buy Perspective Therapeutics stock online?
You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-29 | 15.44 | 15.58 | 15.66 | 15.37 |
Aug-30 | 15.54 | 15.80 | 16.13 | 15.54 |
Sep-3 | 15.55 | 14.18 | 15.94 | 13.95 |
Sep-4 | 14.12 | 14.98 | 15.03 | 14.04 |
Sep-5 | 15.00 | 15.44 | 15.77 | 14.86 |
Sep-6 | 15.57 | 15.26 | 15.65 | 14.51 |
Sep-9 | 15.35 | 15.61 | 15.98 | 15.26 |
Sep-10 | 15.67 | 15.82 | 16.31 | 15.50 |
Sep-11 | 15.63 | 15.65 | 15.86 | 15.21 |
Sep-12 | 15.73 | 15.84 | 16.19 | 15.48 |
Sep-13 | 16.02 | 15.10 | 16.02 | 14.90 |
Sep-16 | 15.20 | 13.12 | 15.28 | 12.95 |
Sep-17 | 13.19 | 13.32 | 13.43 | 12.89 |
Sep-18 | 13.37 | 13.35 | 13.99 | 13.28 |
Perspective Therapeutics Earnings
Perspective Therapeutics Earnings Report: Per Share Perspective Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Perspective Therapeutics Forecast Revenue Growth
Perspective Therapeutics Stock Analysis: Historical quarterly revenues per share for Perspective Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.